Short and Long-term Safety of Micafungin and Other Parenteral Antifungal Agents
Status: | Completed |
---|---|
Conditions: | Infectious Disease |
Therapuetic Areas: | Immunology / Infectious Diseases |
Healthy: | No |
Age Range: | Any |
Updated: | 3/7/2019 |
Start Date: | October 1, 2012 |
End Date: | April 30, 2018 |
A Multicenter Cohort Study of the Short and Long-term Safety of Micafungin and Other Parenteral Antifungal Agents
This multicenter observational cohort study proposes to establish the risks of short and
long-term outcomes in users of parenteral micafungin and in users of other parenteral
antifungal agents from 2005 through 2012 with follow-up until 2017.
long-term outcomes in users of parenteral micafungin and in users of other parenteral
antifungal agents from 2005 through 2012 with follow-up until 2017.
All eligible patients treated with a parenteral antifungal agent at any time during the years
2005-2012 in each of the participating hospitals, will be included in the study.
2005-2012 in each of the participating hospitals, will be included in the study.
Inclusion Criteria:
- hospitalized and treated with parenteral antifungal medication
- first time treatment of the patient with parenteral antifungal in the medical center
was anytime from 2005 through 2012
Exclusion Criteria:
- prior diagnosis of hepatocellular carcinoma
- had received parenteral antifungal therapy during the 6 months prior to index
hospitalization
We found this trial at
6
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials